from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1001/arcA

LFCtreatmentdescriptionclass of inhibitor

0.125

Amikacinug/mL Amikacintranslation

-0.053

Cap5-10ug/mL Capreomycintranslation

0.502

Rox10-50 ug/mL Roxithromycintranslation

-0.274

SM2-5 ug/mL Streptomycintranslation

-0.186

Tet5-10 ug/mL Tetracyclinetranslation

-0.123

Rif0.2-5ug/mL Rifampicintranscription

-0.438

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.080

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.445

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.198

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.425

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.292

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.998

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.780

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.156

NaN30.2-2 mM Sodium aziderespiration

-1.177

Nigericin50 uM Nigericinrespiration

-0.304

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.345

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.408

menadione6-10 ug/mL Menadionerespiration

0.052

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.460

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.459

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.601

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.183

NRP_1Non-replicating persistence stage 1dosRassociated

-0.413

Amp0.2mg/mL AmpicillincellWall

0.568

Cephalexin20-100 ug/mL CephalexincellWall

-0.207

Cerulenin0.32-5 ug/mL CerulenincellWall

0.169

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.362

EMB10-20 ug/mL EthambutolcellWall

-0.683

Eta12-40 ug/mL EthionamidecellWall

-0.635

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.355

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.634

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.089

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.768

BZA0.12 mg/mL BenzamidearomaticAmides

0.713

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.105

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.430

H2O24 mM hydrogen peroxideDNAdamaging

-0.299

Levo10 ug/mL LevofloxacinDNAdamaging

-0.570

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.791

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.006

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.214

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.030

Antimycin12.5-50 ug/mL Antimycin A?

-1.030

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.235

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.292

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.488

PA8240.2-2 ug/mL PA-824?

1.018

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.857

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.186

Verapamil50 uM Verapamil?

-1.740

mercaptoethanol2 mM 2-Mercaptoethanol?

0.561

methoxatin10-20 ug/mL Methoxatin?